Nurix Therapeutics, Inc.

NRIX - CIK 0001549595

Market cap$1.85 B

Rank#2152

SEC filings511

NRIX balance sheet (annual)

The table below shows Nurix Therapeutics, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.

Line item	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Cash & equivalents	$246.96M	$110.00M	$54.63M	$64.47M	$80.51M	$119.36M
Short-term investments	-	-	-	$244.67M	$215.21M	$161.79M
Receivables	-	-	-	-	-	-
Inventory	-	-	-	-	-	-
Total current assets

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.